Improving infection screening for international immigrants Anne J Tunbridge, Joan MacFarlane, Julie Mather, Ann LN Chapman

Tunbridge, Anne; Macfarlane, Joan; Mather, Julie; Chapman, Ann

doi:10.1016/j.jinf.2011.04.066

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The first systematic screening programme for infection in migrants, in the United Kingdom, was introduced in 1965 and involved port-of-entry screening for TB with chest radiographs. 16 – 18 Since 2012, those seeking asylum or refuge in the United Kingdom through formal routes (i.e. through refugee resettlement programmes) undergo pre-entry screening for TB, blood-borne infections (BBI); HIV and hepatitis B and C, syphilis and other sexually transmitted infections (STIs), intestinal helminths and malaria before coming to the United Kingdom.…”

Section: Introductionmentioning

confidence: 99%

Screening for neglected tropical diseases and other infections in refugee and asylum-seeker populations in the United Kingdom

Cinardo

Farrant

Gunn

et al. 2022

Therapeutic Advances in Infection

View full text Add to dashboard Cite

Asylum-seekers and refugees have an increased burden of infections compared with the general population. This has been widely recognised by countries welcoming those fleeing conflict and persecution; however, there are no screening standardised guidelines and regulatory processes. Identification of certain neglected tropical diseases (NTDs) and other infections is important for the health and well-being of the individual in addition to public health and biosecurity. In the United Kingdom, screening for infections at port of entry or after arrival is not mandatory. Those on refugee resettlement programmes will have infection screening as part of their pre-entry health assessment, but no such system exists for those claiming asylum in the United Kingdom. In this article, we have reviewed published, peer-reviewed articles looking at the approaches to screening for NTDs and infectious diseases in the United Kingdom. In addition to this, we have reviewed the literature looking at the acceptability, barriers and facilitators of these screening practices. We found that there is a heterogeneous approach to screening practices in the United Kingdom and a paucity of data to support a single ‘best practice’ approach. Based on our findings, we have made recommendations and consideration for NTD screening strategies and highlighted important areas for future research.

show abstract

Section: Introductionmentioning

confidence: 99%